Is There a Preferred Combination Chemotherapy Regimen for Metastastic Non-Small Cell Lung Cancer?

Is There a Preferred Combination Chemotherapy Regimen for Metastastic Non-Small Cell Lung Cancer? David S. Ettinger Oncologist 2002; 7: 226-233. Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in lung cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Choose the appropriate chemotherapeutic regimen to treat a patient with metastatic non-small cell lung cancer. Identify the advantages and disadvantages of the various regimens to treat stage IV non-small cell cancer. Understand the toxicities associated with each of the various chemotherapeutic regimens. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Jun. 13, 2002 Most Recent Review: June 10, 2005* Most Recent Update: Jun. 13, 2002 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.